Bruce Turner - Chief Strategy Officer at Immunome Inc.

Issuer-level insider activity

Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Bruce Turner since 27 Jun 2025

Reported holdings for Bruce Turner in Immunome Inc.

Form 4 holding Chief Strategy Officer

Immunome Inc.

Security class
Common Stock
Shares / value
42,300
Estimated value
$249,993
Report date
02 Oct 2023
Price
$5.91
Ownership
Direct
Form 4 holding Chief Strategy Officer

Immunome Inc.

Security class
Stock option (right to buy)
Shares / value
110,000
Estimated value
Report date
09 Aug 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Transaction history for Bruce Turner in Immunome Inc.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .